1. Call to order
2. Approval of minutes from July 24, 2020 (vote required)
3. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):
4. Public comment on new drugs to be reviewed for the Medicaid Preferred Drug List
5. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration
6. Executive work session
7. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration (vote required)
8. Retrospective DUR: Conduent, LLC
9. Prospective prior authorization proposals (clinical edits): KEPRO, LLC (vote required)
10. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy (vote required)
Items 11 & 12